Cheers to your post. I do understand the manufacturing complexities and LP's desire to get ahead of it. My share position was averaged quite low so I am fine with current PPS knowing it will improve over time. I do not worry about those things. Nothing will matter until the trial data is released, peer review is established and approval is granted. My posting of an almost 2 year old schedule of events PR was just pointing out that the stated schedule is way off and it was hopeful then and laughable now.